Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Academy of Finland (319257, 323507)
Mary and Georg Ehrnrooth foundation (201900005)
Silmä- ja kudospankkisäätiö (201900001)
Tampere University including Tampere University Hospital, Tampere University of Applied Sciences
- License Information
-
More Information
Article History
Received: 1 April 2022
Accepted: 10 March 2023
First Online: 17 April 2023
Declarations
:
: Tampere University has approval (Dnro 1426/32/300/05) from the National Supervisory Authority for Welfare and Health, Finland, for the research with human embryos. The local Ethical Committee of the Pirkanmaa Hospital District, Finland, has granted a supportive statement to derive, expand, and differentiate hESC lines from surplus embryos for research purposes (R05116). No new cell lines have been derived in this study.
: Not applicable.
: The authors declare that they have no competing interests.
